CTLA4 and familial pancreatic carcinoma: A study in pancreatic cancer demonstrated that CSF-1/CSF-1R blockade up-regulated PD-L1 and CTLA-4, justifying that the combination of TAM reprogramming therapy with ICB may yield maximum effect (311).